middl
east
respiratori
syndrom
coronaviru
mer
cov
first
identifi
year
ago
kingdom
saudi
first
emerg
new
epidem
outbreak
sinc
sever
acut
respiratori
syndrom
coronaviru
sar
cov
broke
east
asia
late
sar
fatal
rate
mer
fatal
rate
novemb
number
laboratori
confirm
infect
number
report
death
six
coronaviru
strain
report
zoonot
ie
transmiss
infect
anim
human
possibl
human
coronavirus
belong
alphacoronaviru
sar
mer
belong
betacoronaviru
first
four
strain
caus
mild
upper
respiratori
tract
infect
like
common
cold
sar
mer
caus
lower
respiratori
infect
bronchiti
bronchiol
report
sar
cov
mer
cov
host
bat
palm
civet
cat
dromedari
camel
gener
coronavirus
envelop
rna
kb
coronaviru
genom
translat
insid
host
cell
two
group
protein
structur
protein
spike
nucleocapsid
n
matrix
envelop
e
protein
rna
depend
rna
polymeras
helicas
coronavirus
enter
host
cell
either
endosom
endosom
entri
human
coronavirus
take
place
via
four
differ
host
cell
receptor
enzym
receptor
sar
cov
hcov
dipeptidyl
peptidas
receptor
mer
cov
aminopeptidas
n
receptor
hcov
sialic
acid
receptor
hcov
hcov
cell
entri
corona
viral
rna
releas
cytoplasm
translat
replic
occur
translat
open
read
frame
yield
two
polypeptid
chain
cleav
form
protein
nsp
polymeras
conserv
activ
site
aspart
take
part
nucleotidyl
transfer
differ
organ
virus
use
modifi
nucleotid
block
polymer
process
report
last
two
decad
first
fda
approv
nucleotid
inhibitor
sofosbuvir
decemb
sofosbuvir
approv
ribavirin
interferon
regimen
addit
also
approv
combin
target
protein
comput
aid
drug
design
cadd
util
comput
softwar
mimic
visual
character
behavior
biolog
molecul
often
use
molecular
model
conjunct
quantit
relationship
qsar
order
test
reactiv
ligand
bind
pattern
protein
activ
molecular
dock
usual
use
order
mimic
bind
ligand
protein
activ
site
use
score
function
neg
dock
score
mean
better
bind
drug
activ
site
target
protein
henc
inhibitori
studi
combin
qsar
molecular
dock
util
evalu
bind
nucleotid
polymeras
inhibitor
sofosbuvir
hcov
polymeras
activ
drug
either
fda
approv
clinic
trial
studi
also
compar
bind
perform
nucleotid
inhibitor
nativ
nucleotid
ribavirin
structur
nucleotid
nucleotid
inhibitor
first
sketch
use
scigress
follow
geometri
optim
use
molecular
mechan
forc
field
method
structur
optim
use
parameter
method
water
optim
structur
examin
calcul
ir
vibrat
spectra
use
method
order
ensur
real
neg
vibrat
final
structur
quantum
mechan
optim
accord
densiti
function
theori
dft
use
function
dzvp
basi
set
follow
calcul
ir
vibrat
spectra
level
stage
structur
final
optim
becom
readi
qsar
dock
calcul
scigress
softwar
use
calcul
qsar
paramet
order
compar
activ
stabil
investig
nucleotid
atp
utp
ctp
gtp
activ
modif
sofosbuvir
respect
addit
ribavirin
qsar
paramet
calcul
structur
qsar
paramet
includ
total
energi
kcalmol
heat
format
kcalmol
dielectr
energi
kcalmol
steric
energi
kcalmol
dipol
moment
deby
electron
affin
ev
ioniz
potenti
ev
log
p
molar
refract
polariz
solvent
access
surfac
area
frontier
energi
gap
ev
human
coronaviru
hcov
polymeras
sequenc
six
human
strain
coronavirus
mer
sar
download
nation
center
biotechnolog
inform
ncbi
protein
databas
http
wwwncbinlmnihgovprotein
nineteen
polymeras
sequenc
uniqu
amino
acid
conserv
activ
site
amino
acid
select
given
strain
follow
four
two
mer
one
sar
six
four
two
multipl
sequenc
align
perform
use
clustal
omega
web
server
http
wwwebiacuktoolsmsaclustalo
european
bioinformat
institut
align
present
help
espript
web
server
http
espriptibcpfrespriptespript
web
server
http
zhanglabccmbmedumicheduitass
use
gener
structur
download
polymeras
five
model
gener
sequenc
model
valid
perform
use
version
four
structur
analysi
verif
server
save
http
servicesmbiuclaedusav
four
program
use
valid
present
model
procheck
verifi
prove
errat
along
model
web
chain
b
pdb
file
model
show
interact
nucleotid
drug
activ
site
polymeras
involv
bind
two
dival
metal
ion
two
aspart
conserv
activ
site
model
adopt
dock
calcul
order
readi
dock
step
protein
model
minim
use
implement
scigress
optim
structur
drug
nucleotid
use
dock
calcul
nineteen
protein
model
dock
atp
gtp
ctp
utp
sofosbuvir
ribavirin
dock
calcul
perform
use
scigress
softwar
assum
ligand
flexibl
activ
site
dock
experi
perform
three
time
averag
valu
dock
score
record
duncan
multipl
rang
test
perform
obtain
data
order
point
significantli
differ
mean
dock
score
use
spss
softwar
version
remov
water
ligand
except
addit
miss
h
atom
geometri
optim
use
forc
field
hepat
c
viru
rdrp
pdb
id
dock
use
ligand
comparison
figur
show
align
hcov
polymeras
sequenc
differ
hcov
strain
solv
structur
hepat
c
viru
polymeras
pdb
id
secondari
structur
hcv
polymeras
present
top
sequenc
order
highlight
conserv
activ
site
two
consecut
aspart
protrud
beta
turn
structur
conserv
amino
acid
structur
hcv
obviou
import
observ
present
work
base
conserv
activ
site
amino
acid
backbon
hold
amino
acid
suggest
manner
interact
hcv
henc
inhibit
hcov
polymeras
possibl
use
nucleotid
inhibitor
region
around
conserv
activ
site
aspart
select
perform
activ
site
randomli
select
model
contain
follow
amino
acid
amino
acid
conserv
except
amino
acid
number
glutam
e
betacoronaviru
threonin
tabl
show
calcul
valu
quantit
relationship
qsar
paramet
valu
calcul
dft
function
optim
structur
nucleotid
atp
utp
ctp
gtp
analogu
sofosbuvir
respect
ribavirin
tabl
show
paramet
reflect
stabil
structur
dielectr
energi
steric
energi
heat
format
frontier
energi
gap
energi
tabl
show
paramet
reflect
reactiv
structur
dipol
moment
electron
affin
molar
refract
polariz
log
p
solvent
access
surfac
area
nucleotid
analogu
probabl
similar
parent
nucleotid
stabil
paramet
show
favor
valu
bold
number
tabl
hand
nucleotid
analogu
stabl
compar
ribavirin
major
stabil
paramet
present
tabl
underlin
valu
appar
steric
energi
heat
format
energi
gap
paramet
lower
better
valu
nucleotid
analogu
compar
ribavirin
similar
tabl
present
comparison
nucleotid
analogu
parent
nucleotid
drug
ribavirin
time
term
paramet
describ
structur
reactiv
instead
structur
stabil
tabl
reveal
nucleotid
analogu
reactiv
parent
nucleotid
bold
valu
tabl
brought
higher
better
valu
dipol
moment
solvent
access
surfac
area
polariz
almost
nucleotid
analogu
valu
better
reactiv
ribavirin
underlin
valu
tabl
recogn
higher
better
valu
dipol
moment
surfac
access
surfac
area
polariz
molar
refract
moreov
log
p
show
studi
compound
hydrophob
compar
parent
nucleotid
ribavirin
may
facilit
passag
membran
atp
utp
ctp
gtp
sofosbuvir
ribavirin
activ
form
dock
activ
site
protein
model
hcov
strain
addit
solv
structur
hcv
rdrp
pdb
id
averag
valu
dock
score
test
signific
differ
use
duncan
multipl
rang
test
spss
softwar
packag
hcov
model
dock
score
valu
show
statist
insignific
differ
parent
nucleotid
analogu
drug
impli
possibl
equal
competit
bind
hcov
activ
site
nevertheless
model
show
significantli
better
dock
nucleotid
eg
ctp
six
significantli
better
dock
score
valu
compar
atp
utp
gtp
three
significantli
better
valu
compar
sofosbuvir
respect
nucleotid
strain
dock
score
investig
drug
show
statist
signific
superior
ribavirin
almost
hcov
model
fortun
except
show
seven
significantli
better
result
compar
ribavirin
hand
show
three
significantli
better
dock
score
compar
ribavirin
show
three
significantli
better
result
compar
ribavirin
show
one
significantli
better
valu
compar
ribavirin
figur
show
averag
dock
score
valu
hcov
strain
hcv
polymeras
dock
nucleotid
inhibitor
ribavirin
error
bar
present
standard
deviat
hcov
strain
present
color
circl
diamond
present
hcv
sar
mer
present
larger
gray
orang
circl
respect
clarif
mer
cov
cov
cov
cov
cov
rhythm
averag
dock
score
rank
show
prioriti
follow
ribavirin
hand
sar
cov
show
prioriti
ribavirin
follow
averag
dock
score
sar
cov
mer
cov
better
hcv
suggest
potent
inhibitori
perform
mer
cov
sar
cov
report
hcv
two
mer
cov
model
model
gener
sequenc
id
select
investig
perform
dock
studi
select
base
valid
data
calcul
save
server
prefer
allow
disallow
region
ramachandran
plot
respect
select
model
versu
respect
model
moreov
overal
qualiti
factor
select
model
versu
one
figur
show
interact
take
place
ligand
gtp
hcv
solv
structur
pdb
id
mer
cov
dock
structur
dock
score
kcalmol
polymeras
interact
pattern
occur
case
case
hcv
gtp
interact
hand
gtp
form
polar
contact
mer
cov
polymeras
hcv
mer
cov
polymeras
form
coordin
bond
gtp
facilit
bind
type
interact
suggest
strong
bind
henc
potent
inhibit
perform
nucleotid
inhibitor
use
drug
mer
cov
hcov
polymeras
figur
produc
use
pymol
softwar
pymol
molecular
graphic
system
figur
show
ligand
interact
diagram
plot
use
maestro
releas
maestro
llc
new
york
ny
select
mer
cov
model
ligand
sofosbuvir
ribavirin
dock
polymeras
activ
site
pocket
use
sigress
softwar
drug
form
activ
site
pocket
amino
acid
addit
metal
interact
form
backbon
structur
solid
arrow
fig
side
chain
dot
arrow
form
mer
cov
polymeras
yet
metal
interact
stabil
complex
dock
score
kcalmol
respect
hand
sofosbuvir
form
one
mer
cov
polymeras
activ
site
amino
acid
involv
format
backbon
side
chain
respect
metal
interact
also
present
dock
score
kcalmol
sofosbuvir
respect
ribavirin
form
two
mer
cov
polymeras
side
chain
backbon
accompani
metal
interact
dock
score
kcalmol
hand
hcv
dock
result
show
nearli
similar
result
fig
sofosbuvir
ribavirin
form
one
hcv
polymeras
side
chain
backbon
backbon
respect
dock
score
kcalmol
respect
similar
case
mer
cov
form
dock
score
kcalmol
respect
metal
interact
report
ribavirin
format
case
hcv
mer
cov
provid
stabil
proteinligand
complex
henc
inhibit
viral
polymeras
function
sinc
polymeras
activ
site
free
bind
nucleotid
polymer
process
complet
gray
smudg
fig
indic
water
expos
atom
group
oh
group
water
expos
henc
format
interact
activ
site
vicin
may
occur
consequ
add
stabil
proteinligand
complex
may
prove
studi
dynam
manner
interact
occur
hcov
strain
amino
acid
involv
format
ligand
amino
acid
compris
activ
site
pocket
polymeras
repeat
amino
acid
form
differ
strain
viru
base
data
qsar
molecular
dock
one
conclud
polymeras
drug
could
effect
potent
inhibitor
hcov
polymeras
includ
recent
outbreak
mer
cov
inhibit
take
place
format
nucleotid
inhibitor
protein
conserv
activ
site
pocket
amino
acid
metal
interact
interact
strengthen
bind
drug
protein
activ
site
would
use
examin
bind
molecular
dynam
simul
advantag
low
toxic
due
low
concentr
blood
emerg
natur
prodrug
convert
activ
form
insid
target
cell
report
hepat
c
viru
hcv
optim
may
requir
increas
potenc
drug
fit
activ
site
pocket
polymeras
precis
modif
carbon
ribos
ring
may
result
potent
inhibitor
probabl
abl
stop
replic
hcov
hcv
zikv
qsar
dock
studi
investig
nucleotid
analogu
ribavirin
unfold
two
promis
keyston
treatment
wide
varieti
hcov
strain
includ
recent
mer
cov
result
dock
hcv
hcov
suggest
metal
interact
strongli
contribut
bind
nucleotid
inhibitor
polymeras
activ
site
henc
protein
inhibit
mer
cov
model
yield
better
dock
score
compar
ribavirin
would
suggest
lunch
experiment
studi
potenc
mer
cov
number
possibl
modif
optim
lead
compound
may
use
increas
potenc
drug
mer
cov
polymeras
aae
suggest
research
plan
wrote
manuscript
construct
tabl
figur
smm
made
core
calcul
wme
share
scientif
discuss
revis
whole
manuscript
gave
idea
present
tabl
data
statist
